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Abstract
Background: Presence of antigen presenting cells, expression of costimulatory molecules, the
strength of first signal and cytokine milieu are quite important in influencing the reactivation of
differentiated Th1 and Th2 cells.
Results: In the present study, we have analyzed the concerted action of pro-Th1 and pro-Th2
cytokines in the presence of B cells, peritoneal and splenic macrophages as antigen presenting cells
and varied concentration of first (anti-CD3 Ab) and second (B7-1 transfectant) signals on the
proliferation and cytokine secretion by Th1 and Th2 cells. Interesting observations were made that
IFN-γ significantly augmented the secretion of IL-4 by Th2 cells when either B cells or splenic or
peritoneal macrophages were used as APC. Further, IFN-γ significantly inhibited the proliferation
of Th1 cells only in the presence of peritoneal macrophages. We have also observed that B cells
could significantly respond to cytokines to further enhance the proliferation and cytokine release
by Th1 and Th2 cells. But not much effect on addition of exogenous cytokines IL-1, IL-4, IL-5, IL-
12 was observed on the proliferation of Th1 and Th2 cells in the presence of macrophages. In
contrast, both IFN-γ and IL-2 significantly enhanced the production of IL-4 and IL-5 respectively, by
Th2 cells in presence of B cells, splenic and peritoneal macrophages. Another important
observation was that the addition of B7-1 transfectants in the cultures, which were stimulated with
low dose of anti-CD3 Ab significantly, enhanced the proliferation and cytokine secretion.
Conclusion: This study indicates involvement of different type of APCs, cytokine milieu, dose of
first and second signals in a concerted manner in the outcome of the immune response. The
significance of this study is that the immunization with antigen along with costimulatory molecules
may significantly reduce the dose of antigen and can generate better immune response than antigen
alone.
Background
On the basis of lymphokines profile, CD4+ T cells can be
differentiated into Th1 and Th2 subtypes. Th1 cells secrete
IL-2, IFN-γ, lymphotoxin, etc., and are mainly involved in
the generation of cell-mediated immunity. Th2 cells
secrete IL-4, IL-5, IL-6, etc., and are generally involved in
humoral immunity [1,2]. These differentiated cells are the
effector arms of the immune system that respond more
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encountered previously and reflect the pre-existence of
clonally expanded populations of antigen-specific lym-
phocytes. Hence it is quite crucial to study the factors that
govern the reactivation of the differentiated Th1 and Th2
cells. Many factors such as antigen presenting cells
(APCs), pro-Th1 and proTh-2 cytokines, strength of first
signal and expression of costimulatory molecules may
influence the activation of Th1 and Th2 cells [3-6]. Anti-
gen presenting cells like B cells, macrophages and den-
dritic cells are critical players in the immune response.
Dendritic cells are potent activators of naïve T cells but it
has been reported that B cells are the most potent APCs in
inducing proliferation of differentiated Th2 cells and
splenic macrophages for differentiated Th1 cells [7]. Fur-
ther, it has also been suggested that peritoneal macro-
phages are favored APCs for both Th1 and Th2 cells.
However, it has also been shown that B cells can function,
as APCs for Th1 cells but for Th2 cells, the presence of IL-
1 is required [8]. The strength of signaling through MHC-
peptide (MHCP) can also affect the activity of terminally
differentiated Th1 and Th2 cells. It has been reported that
differential signaling via anti-CD3 mAb inhibits IL-2-
dependent proliferation of Th1 but not Th2 cells [9,10].
The expression of costimulatory molecules on APCs is
also crucial for the optimum activation of T cells and
therefore may have relevance with diseases [11]. Array of
costimulatory molecules are expressed on the surface of
APCs but the best-defined costimulators are B7-1 and B7-
2 [12-14]. It has been reported that B7-1 and B7-2 and
presence of pro-Th1 (IL-2, IL-12, IFN-γ) and pro-Th2 (IL-
4) cytokines can differentially regulate the activation of
Th1 and Th2 cells [14-16].
It appears that APCs, costimulatory molecules and pro-
Th1 and pro-Th2 cytokines operate in a complex and con-
certed manner that can manipulate the activation of effec-
tor Th1 and Th2 cells. To address this issue, we studied the
role of pro-Th1 and pro-Th2 cytokines in the activation of
Th1 and Th2 cells when B cells, splenic and peritoneal
macrophages were used as APCs. Further, the role of dif-
ferent doses of first (anti-CD3 Ab) and second signals (B7-
1 transfectant) was also studied. It was observed that reg-
ulation of the activation of Th1 and Th2 cells is not a mere
function of cytokines but can be significantly modulated
by the type of APCs and dose of first and second signals.
Results
Influence of pro-Th1 (IL-2, IL-12 and IFN-γ) and pro-Th2
(IL-4) cytokines on the proliferation and IFN-γ secretion
by Th1 cells when B cells, splenic and peritoneal macro-
phages were used as a source of APCs. In the present study
we have chosen very well characterized and widely stud-
ied Th1 (pGL-10, AE7) and Th2 clones (D10G4.1). Anti-
gen-pulsed and gamma-irradiated B cells and
macrophages were used as APCs. We observed the maxi-
mum proliferation of Th1 cells with peritoneal macro-
phages (49590 ± 3056 cpm) followed by splenic
macrophages (29057 ± 1639 cpm) (Fig. 1a). Minimum
proliferation (9945 ± 1020 cpm) was observed when B
cells were used as a source of APCs. Interestingly, when
either IL-4 or IL-12 was added into the cultures, there was
a significant (p < 0.001) enhancement in the proliferation
of Th1 cells when B cells were used as a source of APCs. It
may also be noted here that in all the experiments, most
potent dose of cytokines was used that was selected after
Influence of Pro-Th1 (IL-2, IL-12, IFN-γ) and Pro-Th2 (IL-4) cytokines on the proliferation and IFN-γ secretion when B ells, splenic macrophages and peritoneal macr phages were used as APCsFigure 1
Influence of Pro-Th1 (IL-2, IL-12, IFN-γ) and Pro-Th2 (IL-4) 
cytokines on the proliferation and IFN-γ secretion when B 
cells, splenic macrophages and peritoneal macrophages were 
used as APCs. pGL-10 Th1 cells were cultured with B cells, 
splenic and peritoneal macrophages and ovalbumin (200 μg/
ml). Cytokines IL-2, IL-4, IL-12 and IFN-γ were also added in 
the cultures. For proliferation, the cultures were pulsed after 
48 h with 3H-thymidine (0.5 μCi/well) and harvested after 
last 16 h of incubation period. Data are expressed as mean ± 
SEM of triplicate wells (Fig. 1a). For IFN-γ, the supernatants 
were collected from the triplicate wells after 48 h of the initi-
ation of cultures, pooled and estimated by ELISA. (Fig. 1b). 
The control cultures comprising of Th1 cells, Th1 cell+Ag, 
APCs+Ag, APCs+Th1 cells showed no discernible change. 
The data presented are from three independent experi-
ments. '*' Represents p < 0.001 and '' represents p < 0.05. 
SMQ and PMQ represent splenic and peritoneal macro-
phages respectively.
b
*


*Page 2 of 10
(page number not for citation purposes)
BMC Immunology 2006, 7:17 http://www.biomedcentral.com/1471-2172/7/17conducting dose dependent experiments (data not
shown). There was a marginal increase with IL-2 (p <
0.05) but IFN-γ failed to bring any noticeable change in
the proliferation of Th1 cells when B cells were used as a
source of APCs. Surprisingly, addition of cytokines (IL-2,
IL-4, IL-12, IFN-γ) could not induce any change in the pro-
liferation with splenic macrophages. In contrast, IFN-γ (p
< 0.05) inhibited the proliferation when peritoneal mac-
rophages were used (Fig. 1a).
We observed maximum secretion of IFN-γ by Th1 cells
when peritoneal macrophages (159700 pg/ml) were used
as a source of APCs followed by splenic macrophages
(93530 pg/ml) and B cells (3466 pg/ml). Interestingly,
the presence of IL-4 (505%) and IL-12 (450%) signifi-
cantly enhanced the secretion of IFN-γ when B cells, but
not splenic and peritoneal macrophages were employed
to present antigen (Fig. 1b). The presence of IL-2 could
not modulate any change in IFN-γ release in the presence
of either B cells or macrophages.
Influence of pro-Th1 (IL-2 and IFN-γ) and pro-Th2 (IL-1,
IL-4 and IL-5) cytokines on the proliferation and IL-4 and
IL-5 production by Th2 cells when B cells, splenic and
peritoneal macrophages were used as a source of APCs.
Peritoneal macrophages (51978 ± 1370 cpm) were the
most potent APCs followed by B cells (24326 ± 1871
cpm) in inducing the proliferation of Th2 cells. Splenic
macrophages (16734 ± 1085 cpm) induced lowest prolif-
eration. Interestingly, IL-1, IL-2 and IL-4 significantly (p <
0.001) enhanced the proliferation of Th2 cells when B
cells and splenic macrophages were used as a source of
APCs (Fig. 2a). No change was observed with IL-5. How-
ever, the proliferation was significantly inhibited by IFN-γ
in the presence of splenic (p < 0.001) and peritoneal (p <
0.05) macrophages.
Th2 cells maximally secreted IL-4 when peritoneal macro-
phages (112.5 pg/ml) were used as a source of APCs fol-
lowed by B cells (44 pg/ml) (Fig. 2b). Splenic
macrophages (6.47 pg/ml) were poor stimulator of Th2
cells for IL-4 secretion. Interestingly, addition of IFN-γ sig-
nificantly augmented the yield of IL-4 irrespective of the
type of APCs used in the study. Addition of IL-1, IL-2 and
IL-5 significantly enhanced the secretion of IL-4 when
splenic and peritoneal macrophages but not B cells were
used as APCs.
There was dramatic increase in the release of IL-5 by Th2
cells with peritoneal macrophages (6533 pg/ml). B cells
(420 pg/ml) and splenic macrophages (230 pg/ml) could
also induce moderate production of IL-5. Addition of IL-
2 significantly increased the production of IL-5 with all
the three APCs (Fig. 2c). Further, incorporation of IL-1
into B cell cultures also enhanced the secretion of IL-5.
Addition of IL-4 and IFN-γ in the cultures failed to show
any dramatic change in the secretion of IL-5.
Influence of first and second signals in the proliferation
and IFN-γ secretion by Th1 cells. After studying the role of
APCs, we also monitored the role of different doses of first
(anti-CD3 Ab) and second (B7-1 transfectants) signals in
the activation of Th1 and Th2 cells (Fig. 3a). The first sig-
nal was provided using low (0.01 μg/ml), moderate (0.05
μg/ml) and high concentration (0.1 μg/ml) of anti-CD3
Ab and second signal in the form of low (5 × 103 cells/
well), moderate (1 × 104 cells/well) and high number (5 ×
104 cells/well) of B7-1 transfectants. Moderate to high but
not low concentration of anti-CD3 Ab induced optimum
proliferation of Th1 cells (Fig. 3a). Interestingly, addition
of high concentration of B7-1 transfectants (5 × 104 cells/
well) into the cultures also successfully enhanced the pro-
liferation of the cells stimulated with low strength of first
signal (p < 0.001) (Fig. 3a). Even though, moderate dose
of anti-CD3 Ab induced the optimum level of prolifera-
tion but the addition of high dose of B7-1 transfectants
further enhanced the proliferation of Th1 cells (p <
0.001). In contrary, delivery of strong first signal in asso-
ciation with high number of B7-1 transfectants showed
inhibitory effect. Low dose of first signal alone failed to
induce the secretion of IFN-γ (Fig 3b). However, with the
increase in the concentration of anti-CD3 Ab (0.05–0.1
μg/ml), detectable level of IFN-γ was noticed. When T cells
were stimulated with low dose of first signal, B7-1 costim-
ulation showed marginal increase in the IFN-γ yield. Inter-
estingly, addition of low to high dose of B7-1 transfectants
in the Th1 cell cultures stimulated with either moderate or
strong first signals could substantially enhance the secre-
tion of IFN-γ (Fig 3b). Similar results were also obtained
in the case of AE7 Th1 cells (data not shown).
Importance of the first and second signals in proliferation
and cytokine (IL-4 and IL-5) secretion by Th2 cells. It was
observed that moderate dose of anti-CD3 Ab induced the
proliferation of Th2 cells (D10G4.1) (Fig 4a). Like Th1
cells, addition of high dose of B7-1 transfectants aug-
mented the proliferation of Th2 cells stimulated with low
dose of anti-CD3 Ab (p < 0.001). Interestingly, B7-1 signal
showed marginal increase in the proliferation with the
moderate dose but inhibition was observed with high
dose of first signal (Fig 4a). Also delivery of B7-1-medi-
ated signal could not show any change in the secretion of
IL-4 when cells were stimulated with low dose of first sig-
nal (Fig 4b). However, high dose of first signal alone
induced significant level of IL-4 secretion. Unlike prolifer-
ation, addition of moderate to high, but not low numbers
of B7-1 transfectants further enhanced the secretion of IL-
4 by Th2 cells that were stimulated with high dose of anti-
CD3 Ab. As observed in the case of IL-4 secretion, similarPage 3 of 10
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Influence of the potency of first and second signals in the proliferati n and IFN-γ secretion by Th1 cellsFigure 3
Influence of the potency of first and second signals in the 
proliferation and IFN-γ secretion by Th1 cells. Cultures were 
set with pGL-10 Th1 cells (5 × 104/well) and the indicated 
concentrations of plate-bound anti-CD3 mAb (0.01 μg/ml) 
and in the presence of different concentrations of CHO-B7-1 
(1 × 103/well, 1 × 104/well, 5 × 104/well). The cultures were 
pulsed after 48 h with 3H-thymidine (0.5 μCi/well) and har-
vested after last 16 h of incubation period. Data are 
expressed as mean ± SEM of triplicate wells (Fig. 3a). Produc-
tion of IFN-γ (Fig. 3b) was estimated by ELISA in the pooled 
culture supernatants collected from the triplicate wells after 
48 h of the initiation of cultures. The data is expressed as ng/
ml. The control cultures comprising Th1 cells, Th1 
cells+CHO-B7-1, Th1 cells+CHO cells, CHO-B7-1 
cells+anti-CD3 Ab, CHO-B7-1 cells showed no noticeable 
change. The data presented are from three independent 
experiments. '*' Represents p < 0.001.
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Influence of Pro-Th1 (IL-2, IFN-γ) and Pro-Th2 (IL-1, IL-4, IL-5) cytokines on the proliferation and IL-4 and IL-5 secretion by Th2 cell  when B cel s, splenic macrophages and pe ito-neal ma r phag s we e used as APCFigure 2
Influence of Pro-Th1 (IL-2, IFN-γ) and Pro-Th2 (IL-1, IL-4, IL-
5) cytokines on the proliferation and IL-4 and IL-5 secretion 
by Th2 cells when B cells, splenic macrophages and perito-
neal macrophages were used as APC. D10G4.1 Th2 cells 
were cultured with B cells, splenic and peritoneal macro-
phages and conalbumin (100 μg/ml). Cytokines IL-1, IL-2, IL-4 
or IL-5 and IFN-γ were also added in the cultures. Cultures 
with peritoneal macrophages also received 1 mM aminogua-
nidine. For proliferation, the cultures were pulsed after 48 h 
with 3H-thymidine (0.5 μCi/well) and harvested after last 16 
h of incubation period. Data are expressed as mean ± SEM of 
triplicate wells (Fig. 2a). For IL-4 (Fig. 2b) and IL-5 (Fig. 2c), 
the supernatants were collected from the triplicate wells 
after 48 h of the initiation of cultures, pooled and estimated 
by ELISA. The data are expressed as pg/ml. The control cul-
tures comprising Th2 cells, Th2 cell+Ag, APCs+Ag, 
APCs+Th2 cells showed no apparent change. The data pre-
sented are from three independent experiments. '*' Repre-
sents p < 0.001 and '' represents p < 0.05. SMQ and PMQ 
represent splenic and peritoneal macrophages respectively.
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(Fig 4c).
Influence of pro-Th1 (IL-2 and IL-12) and pro-Th2 (IL-4)
cytokines in proliferation and IFN-γ secretion by Th1 cells
stimulated with anti-CD3 Ab and B7-1. It was observed
that IL-12 significantly (p < 0.001) enhanced the prolifer-
ation of Th1 cells that were activated with anti-CD3 Ab
and B7-1 (Fig 5a). We also observed that IL-12 enhanced
the secretion of IFN-γ by Th1 cells stimulated with anti-
CD3 Ab and B7-1 (Fig 5b). In control cultures, anti-CD3
Ab alone induced the secretion of IFN-γ and addition of
B7-1 transfectants substantially enhanced its production.
Influence of pro-Th1 (IL-2 and IFN-γ) and pro-Th2 (IL-4)
cytokines in proliferation and IL-4 and IL-5 secretion by
Th2 cells stimulated with anti-CD3 Ab and B7-1. It was
observed that both IL-2 and IL-4 significantly (p < 0.01)
enhanced the proliferation of Th2 cells activated with
anti-CD3 Ab and B7-1 (Fig 6a). Interestingly, IFN-γ not
only inhibited (p < 0.05) the proliferation of Th2 cells
activated with anti-CD3 Ab and B7-1 but also decreased
IL-4 and IL-2 mediated proliferation significantly (p <
0.01). In the control wells, anti-CD3 Ab alone showed
marginal proliferation but when B7-1 transfectants were
added, significant proliferation (p < 0.001) was noticed.
IL-2 further augmented the secretion of IL-4 when Th2
cells were stimulated with anti-CD3 Ab and B7-1 trans-
fectants (Fig 6b). Surprisingly, like IL-2, IFN-γ also upreg-
ulated the secretion of IL-4. When IL-2 and IFN-γ were
used in combination, they showed additive effect. IL-2
induced remarkable amount of IL-5 production by Th2
cells that were activated with anti-CD3 Ab and B7-1 (Fig
6c). We also observed that IL-5 secretion augmented by IL-
2 was significantly decreased on addition of IL-4 and IFN-
γ into the cultures. In the control cultures, we detected sig-
nificant secretion of IL-5 by Th2 cells activated with anti-
CD3 Ab but there was no major change with the addition
of B7-1 transfectants.
Discussion
Both Th1 and Th2 cells play a major role in generating
effective immune response. But Th1 and Th2 cells can also
be devastating in some disease conditions like allergy and
autoimmunity respectively [7,18,19]. Many factors like
the strength of first signal, expression of costimulatory
molecules, presence of cytokines, interaction with differ-
ent APCs, etc., can influence the activation of Th1 and Th2
cells [7-10,13-16]. But how the concerted action of these
factors influence their activation is not very well docu-
mented. It is therefore of enormous interest to know how
these factors govern the proliferation, cytokine produc-
tion and development of effector function of Th1 and Th2
cells. We therefore conducted this study to investigate the
role of pro-Th1 and pro-Th2 cytokines in the activation of
Influence of the potency of first and second signals on the proliferati n of Th2 cells and ecretion f IL-4 and IL-5Figure 4
Influence of the potency of first and second signals on the 
proliferation of Th2 cells and secretion of IL-4 and IL-5. Cul-
tures were set with (5 × 104/well) D10G4.1 Th2 cells and the 
indicated concentrations of plate-bound anti-CD3 mAb (0.01 
μg/ml) and in the presence of different concentrations of 
CHO-B7-1 (1 × 103/well, 1 × 104/well, 5 × 104/well). For 
proliferation (Fig. 4a), all the cultures were pulsed after 48 h 
with 3H-thymidine (0.5 μCi/well) and harvested after the last 
16 h of incubation period. Data are expressed as mean ± 
SEM of triplicate well. Production of IL-4 (Fig. 4b) and IL-5 
(Fig. 4c) was estimated by ELISA. The supernatants were 
pooled from the triplicate wells after 48 h of the initiation of 
cultures. The data are expressed as pg/ml. The control cul-
tures comprising of Th2 cells, Th2 cells+CHO-B7-1, Th2 
cells+CHO cells, CHO-B7-1 cells+anti-CD3 Ab, CHO-B7-1 
cells showed no remarkable change. The data presented are 
from four independent experiments. '*' Represents p < 
0.001.
0.01 0.05 0.1
0
20000
40000
60000
80000
 Anti-CD3 Ab
 B7.1 (1x103)
 B7.1 (1x104)
 B7.1 (5x104)
T
h
2 
ce
ll 
p
ro
lif
er
at
io
n
Anti-CD 3 Ab (m icrogram /m l)
*
0.01 0.05 0.1
0
2000
4000
6000
8000
 Anti-CD3 Ab
 B7.1 (1x103)
 B7.1 (1x104)
 B7.1 (5x104)
IL
-5
 (
p
ic
o
g
ra
m
/m
l)
Anti-CD3 Ab (microgram/ml)
0 .01 0.05 0.1
0
25
50
75
4000
8000
12000
16000
 U
 B 7.1 (1x103)
 B 7.1 (1x104)
 B 7.1 (5x104)
IL
-4
 (
p
g
/m
l)
Anti-C D-3 Ab (m icrogram /m l)
Anti-CD3 AbPage 5 of 10
(page number not for citation purposes)
BMC Immunology 2006, 7:17 http://www.biomedcentral.com/1471-2172/7/17rested Th1 and Th2 cells. This activation is caused by dif-
ferent concentration of anti-CD3 Ab and B7-1 transfect-
ants as a source of first signal and second signals
respectively and B cells, splenic and peritoneal macro-
phages as APCs.
Influence of Pro-Th1 (IL-2 and IFN-γ) and Pro-Th2 (IL-4) cytokines on the proliferation and IL-4 and IL-5 secretion by Th2 cells stimulated with anti-CD3 Ab B7-1Figur  6
Influence of Pro-Th1 (IL-2 and IFN-γ) and Pro-Th2 (IL-4) 
cytokines on the proliferation and IL-4 and IL-5 secretion by 
Th2 cells stimulated with anti-CD3 Ab and B7-1. D10G4.1 
Th2 cells were cultured with anti-CD3 Ab (0.01 μg/ml) in the 
presence of CHO-B7-1 (5 × 104/well). Cytokines IL-2, IL-4 
or IFN-γ alone or in combinations were also added in to the 
cultures. For the proliferation (Fig. 6a), cultures were pulsed 
after 48 h with 3H-thymidine (0.5 μCi/well) and were har-
vested after last 16 h of incubation period. Data are 
expressed as mean ± SEM of triplicate wells. IL-4 (Fig. 6b) 
and IL-5 (Fig. 6c) were estimated by ELISA in the pooled 
supernatants collected from the triplicate wells after 48 h of 
the initiation of the cultures. The control cultures comprising 
Th2 cells, CHO-B7-1+Th2 cells, CHO+Th2 cells, CHO-B7-
1, CHO showed no considerable change except that IL-5 
secretion was 1995 pg/ml when D10G4.1 Th2 cells were 
incubated with CHO-B7.1 in the absence of anti-CD3 Ab. 
The data presented are from three independent experi-
ments. '*' Represents p < 0.001, '†' represents p < 0.01 and 
' ' represents p < 0.05.
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Influence of Pro-Th1 (IL-2 and IL-12) and Pro-Th2 (IL-4) cytokines on the proliferation and IFN-γ secretion by Th1 ells stimulated with anti-CD3 Ab and B7-1Figure 5
Influence of Pro-Th1 (IL-2 and IL-12) and Pro-Th2 (IL-4) 
cytokines on the proliferation and IFN-γ secretion by Th1 
cells stimulated with anti-CD3 Ab and B7-1. pGL-10 Th1 
cells were cultured with anti-CD3 Ab (0.01 μg/ml) in the 
presence of CHO-B7-1 (5 × 104/well). Cytokines IL-2, IL-4 
or IL-12 alone or in combinations were also added into the 
cultures. For proliferation (Fig. 5a), cultures were pulsed 
after 48 h with 3H-thymidine (0.5 μCi/well) and were har-
vested after last 16 h of incubation period. Data are 
expressed as mean ± SEM of triplicate wells. IFN-γ (Fig. 5b) 
was estimated by ELISA in the pooled culture supernatants 
collected from the triplicate wells after 48 h of the initiation 
of cultures. The control cultures comprising of Th1 cells, 
CHO-B7-1+Th1 cells, CHO+Th1 cells, CHO-B7-1, CHO 
showed no noticeable change. The data presented are from 
three independent experiments. '*' Represents p < 0.001.
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BMC Immunology 2006, 7:17 http://www.biomedcentral.com/1471-2172/7/17We observed that as compared to B cells and splenic mac-
rophages, maximum proliferation and cytokine secretion
by Th1 and Th2 cells was observed when peritoneal mac-
rophages were used as APCs. This may be due to the fact
that thioglycollate elicited peritoneal macrophages release
cytokines and express high level of costimulatory mole-
cules [19,20]. Interestingly, IFN-γ, in the presence of peri-
toneal macrophages but not splenic macrophages and B
cells suppressed the proliferation of Th1 cells mainly. The
reason for this observation may be explained by the fact
that on interaction with Th1 cells, macrophages produce
nitric oxide (NO). Thioglycollate elicited macrophages are
high producers of IL-12. IL-12 skews immune response
towards Th1 cells, which in turn produce IFN-γ. Recently,
it has been reported in the case of T. crassiceps that perito-
neal macrophages impair T cell proliferation by secreting
NO. Nitric oxide also contributes to asthma pathogenesis
by selective down-regulation of Th1 responses [21-23]. It
may be inferred from this finding that activated macro-
phages interact with Th1 cells in a manner that leads to
high production of IFN-γ that can inhibit their prolifera-
tion and impair their capacity to respond to cytokines.
This strategy may be utilized by intracellular pathogens in
taming macrophages in their favor and thereby suppress-
ing Th1 response [21-25]. Therefore targeting antigen to
other APCs like B cell and dendritic cell for the activation
of Th1 cells during intracellular infection of macrophages
may avoid immunosuppression. Our observation shows
that B cells can significantly respond to cytokines to fur-
ther enhance the proliferation and cytokine release by Th1
and Th2 cells (Fig. 1, 2). Addition of exogenous cytokines
(IL-1, IL-4, IL-5, IL-12) had no effect on the proliferation
of Th1 and Th2 cells in the presence of macrophages (Fig.
1, 2). In contrast, IFN-γ and IL-2 significantly enhanced
the production of IL-4 and IL-5 respectively by Th2 cells in
presence of B cells, splenic and peritoneal macrophages.
This indicates that signals delivered by IFN-γ or IL-2
worked irrespective of the type of APCs. IL-5 is an impor-
tant mediator of eosinophilia in mice with parasite infec-
tions. It has also been shown that mice administered IL-2
developed eosinophilia. Therefore our study indicates
that precaution should be taken while using IL-2 for
immunomodulation, since despite inhibiting, it induces
eosinophilia [26]. Further, the finding that IFN-γ induces
IL-4 secretion by Th2 cells is in contrast with the earlier
findings but recently, it has been reported that IFN-γ has
dual role in the activation of Th2 cells [27,28]. High con-
centration of IFN-γ can inhibit whereas low dose can
prime cells to develop into IL-4 secreting Th2 cells. This
indicates that depending on the concentration, a cytokine
can have dual role on Th1 and Th2 cells and subsequently
on the outcome of the disease. Further, these observations
indicate that cytokine-mediated regulation of polariza-
tion of CD4+ T cells to the Th1 or Th2 phenotype is more
complex than originally envisioned in the studies that
examined the dominant role of cytokines [27-29].
Our observation also indicates that IFN-γ can act directly
on differentiated Th2 cells to enhance IL-4 production
and not necessarily through APCs. IFN-γ enhanced the
secretion of IL-4 when Th2 cells were stimulated with anti-
CD3 Ab and B7-1 transfectant. However, this does not
rule out the possibility of IFN-γ working on Th2 cells
through APCs as well. This is evident by the fact that the
production of IL-4 was higher when stimulated with APCs
as compared to anti-CD3 Ab and B7-1 transfectants (Fig.
2b, 6b).
Another important observation of the study was that
appropriate dose of first signal and expression of costim-
ulatory molecules is quite crucial for the optimum prolif-
eration and cytokine secretion by Th1 and Th2 cells.
Interestingly, addition of B7-1 transfectants in the cultures
using low dose of anti-CD3 Ab (0.01–0.05 μg/ml), signif-
icantly enhanced the proliferation and cytokine secretion.
The significance of this observation is that it may have
important application in vaccine design and develop-
ment. Formulating a device using costimulatory mole-
cules may elicit optimal T-cell response with even low
dose of antigen. Therefore, one can overcome the prob-
lems related to high dose inoculation of antigen. We also
observed that a high dose of first signal delivered in the
form of anti-CD3 Ab inhibits the proliferation of Th1 and
Th2 cells. This indicates that high dose of antigen and con-
stant stimulation can suppress the T cells. This may
explain why the immune response generated due to DNA
vaccination fails to evoke a better response than protein
antigens. Further, constant stimulation with high dose of
antigen can limit protective function of T cells [29-32].
Thus it is quite obvious from our study that not only the
presence of particular cytokines, but also the type of APCs
and the dose of first and second signals may have signifi-
cant impact on the activation of Th1 and Th2 cells. So it is
quite necessary to take into account the concerted action
of the type of APCs, effectiveness of first and second sig-
nals and the presence of cytokines while studying the acti-
vation of rested Th1 and Th2 cells. This study may be of
paramount importance when studying the in vivo
immune response generated by the vaccines. Different
individuals respond in a different way to vaccines. One
possible reason may be the difference in type of APCs that
encounter the antigen, the density of antigen, the expres-
sion of costimulatory molecules and cytokine milieu.
Thus our experiments emphasize the need for detailed
analysis of the host immune system before immunizing
with a vaccine or immunotherapeutic agents to generate
effective immune response. Further, our study suggests
that immunization with antigen along with costimulatoryPage 7 of 10
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and can generate better immune response than observed
with high dose of antigen.
Conclusion
Our study demonstrates the involvement of different type
of APCs, cytokine milieu, dose of first and second signals
in a concerted manner in the outcome of the immune
response. The significance of this study is that the immu-
nization with antigen along with costimulatory molecules
may considerably decrease the quantity of antigen and
can produce better immune response than antigen alone.
Methods
Animals
Inbred female BALB/c and C3He mice, 6–10 weeks old,
were obtained from the Institute's Animal House Facility,
National Institute of Immunology, New Delhi and
National Institute of Nutrition, Hyderabad. The animals
were fed on standard pellet diet and water ad libitum. All
the mice were housed under standard conditions at the
Institute's Animal Facility.
Chemical and reagents
Fetal calf serum was purchased from Harlan Sera Lab
(Crawley Down, GB), RPMI 1640, DMEM and HBSS from
GIBCO (Grand Island, NY) and L-glutamine, L-pyruvate,
penicillin and streptomycin were from Serva (Heidelberg,
Germany). Recombinant IL-1 cytokine was procured from
Genzyme (Cambridge MA) and recombinant IL-2, IL-4,
IL-5, IL-12, and IFN-γ from Pharmingen (San Diego, CA).
For ELISA of IL-4, IFN-γ and IL-5, the capture and detec-
tion (biotinylated) antibodies were obtained from
Pharmingen (San Diego, CA). General chemicals used in
the study were procured from the Sigma Chemical Co. (St.
Louis, MO). 3H-thymidine was the product of Amersham
Pharmacia Biotech AB (Uppsala, Sweden).
Cell lines and hybridomas
The Th2 clone D10G4.1 (TIB-224) was procured from
American Type Culture Collection (ATCC), (Rockville,
MD). Th1 clone (pGL-10) was a kind gift by Dr. V. M.
Sanders, Department of Molecular Virology, Immunology
and Medical Genetics, Ohio State University, Columbus,
Ohio and Th1 clone (AE7) was a kind gift by Dr. J. Renga-
rajan, Department of Immunology and Infectious Dis-
ease, Harvard School of Public Health, Boston, MA. Anti-
CD3 Ab (145.2C11) hybridoma was kind gift from Prof.
C. A. Janeway, Jr. (Yale University, New Haven, CT). The
CHO-B7-1 transfectants were a kind gift from Dr. A. Ochi,
John P. Robarts Research Institute, Ontario, Canada.
Medium
Cells were cultured in RPMI 1640 or DMEM medium sup-
plemented with 10% FCS, L-glutamine (2 mM), penicillin
(50 μg/ml), streptomycin (50 μg/ml), HEPES (100 mM)
and 2-ME (0.05 mM).
Maintenance of antigen-specific Th1 and Th2 cells
The Th1 clones were maintained following the studied
protocols [23] and Th2 clones were maintained according
to ATCC protocol.
The cultures for Th cell proliferation were set using differ-
ent concentrations (1 × 103–105 cells/well) of stimulator
cells (macrophages untreated or treated with IFN-γ and
LPS-activated B cells) and T cells (2 × 104/well) in the pres-
ence or absence of B7-1 Abs. The cultures were also set
using HamIg as controls for anti-B7-1 Ab. On day 5 of
MLR cultures, [3H]-thymidine was added and the cultures
were harvested after 16 h and assayed for DNA synthesis
by beta scintillation counting.
Preparation of antigen presenting cells (B cells, splenic and 
peritoneal macrophages)
A single cell suspension of mice spleens was prepared in a
balanced salt solution (BSS). The RBCs were depleted by
treatment with ACK lysis solution. The adherent splenic
macrophages were removed by plating on the plastic Petri
plates (Grenier, Germany) for two hour at 37°C and 7%
CO2. The adherent cells were washed several times with
BSS and then removed by gentle scraping with the rubber
policeman from the plate and used as adherent splenic
macrophages. The nonadherent cells were treated sequen-
tially on ice for 45 min, with a mixture of anti-Mac-2, Mac-
3, Thy1, CD4 and CD8 Abs followed by incubation with
baby rabbit complement at 37°C for 45 min. The purity
of cells stained with anti-IgM Ab by indirect immunoflu-
orescence, were nearly 80%, as analyzed by flow cytome-
try (Becton Dickinson, Mountain view, CA).
The PECs (peritoneal exudate cells) were harvested from
mice inoculated 4 days previously with 2 to 3 ml of Thi-
oglycollate. The cells were washed with cold BSS. The
macrophages were obtained by adhering on plastic Petri's
dishes for 1 h at 37°C, followed by washing several times
in cold BSS. The cells were then removed from Petri dishes
by gentle scraping with the rubber policeman, washed
with BSS and resuspended in medium.
The proliferation and cytokine secretion by Th1 and Th2 
cells using different doses of first and second signals
T helper clones (pGL-10 and D10G4.1) were isolated after
7–9 days of activation with antigen-pulsed splenocytes.
The dead cells were removed by ficoll-histopaque and
washed twice with BSS. The cells (5 × 104/well) were
added in 96w flat bottom microtitre plate, pre-coated
with different doses of anti-CD3 Ab (0.01–0.1 μg/ml) for
2–3 h in PBS (pH 7.0) at 37°C. The wells were washed
three times with BSS. Different concentrations of parafor-Page 8 of 10
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well) were then added to T helper cells.
Similar cultures were also set in combination with differ-
ent cytokines [IL-2 (50 U/ml), IL-4 (100 U/ml), IL-12
(100 U/ml)] for Th1 cells and [IL-2 (50 U/ml), IL-4 (100
U/ml), IFN-γ (100 U/ml)] for Th2 cells. Both Th1 and Th2
cells were also stimulated with anti-CD3 Ab (0.01 μg/ml)
and paraformaldehyde fixed transfectants (5 × 104/well).
The cells were incubated at 37°C/7% CO2. After 48 h, the
cultures were pulsed with 0.5 μCi of 3H-thymidine and
harvested 16 h later by an automatic cell harvester. Radio-
activity incorporated was measured by liquid scintillation
counting and data were expressed as mean counts per
minute (cpm). For the estimation of cytokines (IL-4, IL-5
and IFN-γ), 100 μl of culture supernatant was removed
from each set of triplicate wells after 48 h and pooled for
ELISA.
Estimation of cytokines
The cytokines were estimated as per manufacturer instruc-
tions (Pharmingen) and expressed as pg/ml using recom-
binant cytokines as a standard (Pharmingen).
Proliferation and cytokine secretion by Th1 and Th2 cells 
in response to APCs (B cells, splenic and peritoneal 
macrophages) and cytokines (IL-1, IL-2, IL-4, IL-5, IL-12 
and IFN-γ)
Th1 cells (5 × 104/well) were cultured with gamma-irradi-
ated B cells, splenic macrophages (1 × 105/well) and peri-
toneal macrophages (5 × 104/well) as antigen presenting
cells in 96 w flat-bottom plate. B cells were irradiated at
500 R and splenic and peritoneal macrophages at 3000 R.
Those doses of APCs were chosen which induced the opti-
mum proliferation of Th1 and Th2 cells. In the cultures,
IL-2 (50 U/ml), IL-4 (100 U/ml), IL-12 (100 U/ml), IFN-
γ (1000 U/ml) and ovalbumin (200 μg/ml) were also
added. Th2 cells were cultured with IL-1 (1 ng/ml), IL-2
(50 U/ml), IL-4 (100 U/ml), IL-5 (100 U/ml), IFN-γ
(1000 U/ml) conalbumin (100 μg/ml). Aminoguanidine
(1 mM) was also added to the inhibit nitric oxide produc-
tion in cultures where peritoneal macrophages were used
as APC. The proliferation and cytokine secretion were esti-
mated as described above.
Statistics
Statistical analysis was done using unpaired student's t-
test. '' Represents p < 0.05, '†' p < 0.01, '*' p < 0.001.
Abbreviations
APC: antigen presenting cells; PEC: peritoneal exudates
cells; PMQ: peritoneal macrophages; SMQ: splenic macro-
phages; IFN-γ: interferon-gamma, Ag: antigen.
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